Search by Drug Name or NDC
NDC 68163-0743-04 DRx Choice 200 mg/10mL Details
DRx Choice 200 mg/10mL
DRx Choice is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Raritan Pharmaceuticals Inc. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 68163-0743-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 68163-0743 |
|---|---|
| Product ID | 68163-743_20dc7a0b-4e2c-4743-87f9-5bafffdbf003 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | DRx Choice |
| Proprietary Name Suffix | Fruit Punch |
| Non-Proprietary Name | Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SYRUP |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/10mL |
| Substance Name | GUAIFENESIN |
| Labeler Name | Raritan Pharmaceuticals Inc |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68163-0743-04 (68163074304)
| NDC Package Code | 68163-743-04 |
|---|---|
| Billing NDC | 68163074304 |
| Package | 1 BOTTLE in 1 CARTON (68163-743-04) / 118 mL in 1 BOTTLE |
| Marketing Start Date | 2019-05-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |